TwinBeech Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History

TwinBeech Capital’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-56,322	Closed	-$1.95M	–	782
2022 Q1	$1.95M	Buy	56,322 +7,543	+15%	+$226K	0.09%	246
2021 Q4	$1.43M	Buy	48,779 +20,767	+74%	+$643K	0.08%	282
2021 Q3	$714K	Buy	+28,012	New	+$823K	0.05%	377
2020 Q4	–	Sell	-12,931	Closed	-$713K	–	674
2020 Q3	$713K	Buy	+12,931	New	+$822K	0.15%	204
2020 Q1	–	Sell	-2,570	Closed	-$204K	–	518
2019 Q4	$204K	Buy	+2,570	New	+$152K	0.06%	356

Other funds holding GBT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

TwinBeech Capital's GBT Position: Q2 2022 in Review

TwinBeech Capital sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2022, closing a stake of 56,322 shares — an estimated $1.95M sold.

TwinBeech Capital first reported a position in GBT in Q4 2019 and held it in 5 quarters. The position peaked at $1.95M in Q1 2022. 195 funds tracked by Wall St. Rank hold GBT as of Q2 2022.

TwinBeech Capital reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2022 after selling out during the quarter.
TwinBeech Capital sold 56,322 Global Blood Therapeutics, Inc. shares in Q2 2022, an estimated $1.95M.
TwinBeech Capital first reported a position in Global Blood Therapeutics, Inc. in Q4 2019 and held it in 5 quarters.
TwinBeech Capital's Global Blood Therapeutics, Inc. position peaked at $1.95M in Q1 2022.
195 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2022.

Based on TwinBeech Capital's 13F filing for Q2 2022, filed 15 Aug 2022.